Researchers in Germany have found that the South African and Brazillian variants of the SARS-CoV-2 virus might be able to evade "plasma therapy". The study, which was recently published in the scientific journal called Cell, tested to see how well antibodies induced by infection and vaccination neutralise the South African (B.1.351) variant and the Brazillian (P.1) variant of